<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Chin Med J (Engl)</journal-id><journal-id journal-id-type="iso-abbrev">Chin. Med. J</journal-id><journal-id journal-id-type="publisher-id">CMJ</journal-id><journal-title-group><journal-title>Chinese Medical Journal</journal-title></journal-title-group><issn pub-type="ppub">0366-6999</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26904982</article-id><article-id pub-id-type="pmc">4804429</article-id><article-id pub-id-type="publisher-id">CMJ-129-505</article-id><article-id pub-id-type="doi">10.4103/0366-6999.176997</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Randomized Comparison of the Crush Versus the Culotte Stenting for Coronary Artery Bifurcation Lesions</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Xu-Wei</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Dong-Hui</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Peng</surname><given-names>Hong-Yu</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fan</surname><given-names>Qian</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Qin</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Zhen-Ye</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fan</surname><given-names>Chao</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Li-Yu</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Jing-Hua</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing 100029, China</aff><aff id="aff2"><label>2</label>Key Laboratory of Soft Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing 100190, China</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Jing-Hua Liu, Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing 100029, China E-Mail: <email xlink:href="liujinghua@vip.sina.com">liujinghua@vip.sina.com</email></corresp></author-notes><pub-date pub-type="ppub"><day>05</day><month>3</month><year>2016</year></pub-date><volume>129</volume><issue>5</issue><fpage>505</fpage><lpage>510</lpage><history><date date-type="received"><day>10</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2016 Chinese Medical Journal</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>The crush and the culotte stenting were both reported to be effective for complex bifurcation lesion treatment. However, their comparative performance remains elusive.</p></sec><sec id="st2"><title>Methods:</title><p>A total of 300 patients with coronary bifurcation lesions were randomly assigned to crush (<italic>n</italic> = 150) and culotte (<italic>n</italic> = 150) treatment. The primary endpoint was the occurrence of major adverse cardiac events (MACEs) at 12 months including cardiac death, myocardial infarction, stent thrombosis, and target vessel revascularization. Index lesion restenosis at 12 months was a secondary endpoint. The surface integrals of time-averaged wall shear stress at bifurcation sites were also be quantified.</p></sec><sec id="st3"><title>Results:</title><p>There were no significant differences in MACE rates between the two groups at 12-month follow-up: Crush 6.7%, culotte 5.3% (<italic>P</italic> = 0.48). The rates of index lesion restenosis were 12.7% versus 6.0% (<italic>P</italic> = 0.047) in the crush and the culotte groups, respectively. At 12-month follow-up, the surface integrals of time-averaged wall shear stress at bifurcation sites in the crush group were significantly lower than the culotte group ([5.01 &#x000b1; 0.95] &#x000d7; 10<sup>&#x02212;4</sup> Newton and [6.08 &#x000b1; 1.16] &#x000d7; 10<sup>&#x02212;4</sup> Newton, respectively; <italic>P</italic> = 0.003).</p></sec><sec id="st4"><title>Conclusions:</title><p>Both the crush and the culotte bifurcation stenting techniques showed satisfying clinical and angiographic results at 12-month follow-up. Bifurcation lesions treated with the culotte technique tended to have lower restenosis rates and more favorable flow patterns.</p></sec></abstract><kwd-group><kwd>Bifurcation Lesions</kwd><kwd>Hemodynamics</kwd><kwd>Percutaneous Coronary Intervention</kwd><kwd>Stenting Technique</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>I<sc>NTRODUCTION</sc></title><p>Coronary bifurcation lesion was one of the most challenging subsets in the percutaneous coronary intervention (PCI) due to its lower angiographic success rates and higher risk of procedural complications.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] Currently, single stent implantation in the main vessel with provisional side branch (SB) stenting has been considered the default approach in most coronary bifurcation lesions.[<xref rid="ref3" ref-type="bibr">3</xref>] However, there is still a number of coronary bifurcation lesions need stent coverage both the main vessel and the SB. Bifurcation lesions with large SB, small bifurcation angle, or severe stenosis in SB may be assigned to double stenting group at the very beginning. Several double stenting techniques associated with promising angiographic and clinical outcome have been proposed. Among those, the crush and the culotte techniques are mostly used to provide stent coverage of the whole bifurcation region in clinical practice. However, the optimal double stenting technique is still under debate.</p><p>Abnormal blood flow patterns are known to be associated with cellular proliferation, platelet activation, and inflammation.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>] Altered local hemodynamic profile and associated blood flow disturbances caused by the stent implantation may influence restenosis and stent thrombosis. Both geometric deformation and introduction of stent struts participate in this process. Our previous work and other computational fluid dynamics (CFD) studies performed with ideal coronary bifurcation models have already shown that different stenting techniques bring different hemodynamic conditions and flow patterns.[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref>] To the best of our knowledge, the comparison of long-term local flow disturbances between the crush and the culottes stenting techniques have fewly been studied. The objective of this study was to provide insights into optimal double stent technique comparing clinical and hemodynamic results of the crush with the culotte bifurcation stenting techniques.</p></sec><sec sec-type="methods" id="sec1-2"><title>M<sc>ETHODS</sc></title><sec id="sec2-1"><title>Patient population and randomization</title><p>A total of 300 patients undergoing crush or culotte technique from June 2013 to August 2014 were enrolled in this study. The protocol was approved by the Ethics Committee and written informed consent was given to all participating patients. The inclusion criterion was <italic>de novo</italic> coronary true bifurcation lesion with an SB B2.25 mm in diameter. Exclusion criteria were ST-elevation acute myocardial infarction within 24 h, liver and/or renal dysfunction, left ventricular ejection fraction &#x02264;30%, life expectancy &#x0003c;1 year, a platelet count &#x02264;10 &#x000d7; 10<sup>9</sup>/L, and suspected intolerance to any of the drugs used (aspirin, clopidogrel, and sirolimus).</p><p>The participants were randomly assigned in a 1:1 ratio to either the crush or culotte group.</p></sec><sec id="sec2-2"><title>Medications and stent implantation</title><p>Patients were pretreated with a loading dose of clopidogrel 300 mg prior to the index procedure. Heparin was given as a bolus of 5000 U and a maintenance dose of 100 U/kg. Glycoprotein receptor antagonists were used at the discretion of the operator. After the intervention, aspirin was continued for life and clopidogrel for at least 12 months. The crush technique was typical crush technique performed as Colombo <italic>et al</italic>.[<xref rid="ref8" ref-type="bibr">8</xref>] described. It consists of advancing two stents simultaneously into both the main vessel and SB. Crush stenting results in a triple layer of struts in the proximal main branch wall toward the branching vessel and a double layer of struts at the orifice of the SB. The culotte technique was performed as Chevalier <italic>et al</italic>.[<xref rid="ref9" ref-type="bibr">9</xref>] described. It consists of implanting a first stent from the proximal to the distal segment of the main vessel. A second stent is then placed on the proximal main branch toward the SB through the struts of the first stent. Culotte stenting results in a double layer of struts in the proximal part of the main vessel and the presence of struts in the lumen of the main vessel at the bifurcation site.</p><p>Kissing balloon inflation was mandatory and additional stents to cover a possible dissection was allowed.</p></sec><sec id="sec2-3"><title>Follow-up</title><p>Clinical follow-up was achieved by means of an office visit or telephone contact every 3 months. Angiographic follow-up was scheduled for 12 months after the index procedure, unless there was a clear clinical evidence to perform the angiography earlier. There was no losing case in clinical follow-up. Angiographic follow-up was successfully performed in 127 of crush group and 125 of culotte group, respectively.</p></sec><sec id="sec2-4"><title>Study endpoints and definitions</title><p>The primary endpoint of the study was the occurrence of 1-year major adverse cardiac event (MACE) rate including cardiac death, myocardial infarction, stent thrombosis, and/or target vessel revascularization (TVR). The secondary endpoint was index lesion restenosis. Cardiac death, myocardial infarction, stent thrombosis, and TVR were defined according to the Academic Research Consortium definition.[<xref rid="ref10" ref-type="bibr">10</xref>]</p></sec><sec id="sec2-5"><title>Quantitative coronary angiographic analysis</title><p>Coronary angiograms obtained at baseline, at poststenting, and after 12 months were analyzed offline with CAAS QCA 3D (Version 5.7.1, Pie Medical Imaging B.V., Maastricht, the Netherlands). Quantitative angiographic measurements of the proximal main vessel segment, the distal main vessel segment, and the SB were obtained. Measurements were obtained in the stents and in the margins 5 mm proximal and distal to the stents both main vessel and SB segment.</p><p>Three-dimensional reconstruction of the coronary bifurcations were done primarily with the commercial software CAAS QCA 3D from at least two different projection images with at least 30&#x000b0; difference. The results were then saved as STL files for further CFD analysis.</p></sec><sec id="sec2-6"><title>Computational fluid dynamics simulations and analysis</title><p>The simulations were conducted using the commercial software COMSOL Multiphysics (version 4.2, Comsol, Stockholm, Sweden). Defined boundary conditions are imposed, and the Navier&#x02013;Stokes equations that describe the laminar motion of fluids are numerically solved using numeric grids. The artery walls were assumed rigid while no deformation was taken into account. The blood was considered as a Newtonian incompressible fluid with the density and the viscosity of 1.06 &#x000d7; 10<sup>3</sup> kg/m<sup>3</sup> and 3.5 &#x000d7; 10<sup>&#x02212;3</sup> Pa&#x000b7;s based on documented data, respectively. Human left coronary artery pulsatile velocity measurements were applied at the inlet of the vessel. For the outlets, the downstream microcirculation resistance was considered, and the Murray's law was used to estimate the boundary conditions. The time average wall shear stress (TAWSS) and its surface integral at bifurcation sites were quantified.</p></sec><sec id="sec2-7"><title>Statistical analysis</title><p>We based our power calculations on an expected 1-year primary endpoint event rate of 20% in the crush group, alpha 5%, power 80%, and using a two-sided Chi-square test. To detect a reduction in primary endpoint rate to 10%, 125 patients would be needed in each group. Because of the considerable uncertainty, it was decided to include 150 patients in each group (20% increment).</p><p>Statistical analysis was done with the SPSS version 17.0 (SPSS Inc., Chicago, IL, USA). Continuous variables were presented as a mean and compared by the independent-samples <italic>t</italic>-test. Categorical variables were presented as frequencies with percentages and compared utilizing the Chi-square statistic or Fisher's exact test. Rate-free survival from events were generated by Kaplan&#x02013;Meier analysis, and they were compared using the log-rank test. A <italic>P</italic> &#x0003c; 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>R<sc>ESULTS</sc></title><sec id="sec2-8"><title>Baseline characteristics and procedural data</title><p>Baseline clinical characteristics and risk factors were well-balanced between 2 treatment groups [<xref ref-type="table" rid="T1">Table 1</xref>]. In four-fifths of the cases, the indication for treatment was unstable angina pectoris. The index lesion location was the left anterior descending artery in 66.0%, the circumflex artery in 20.3%, the left main stem in 10.7%, and the right coronary artery in 3.0%, with no difference between the two groups. SB angulation of &#x0003c;50&#x000b0; was seen in 42.8% of the lesions, with no difference between the groups. A final kissing balloon dilatation was performed in significantly less of the patients in the crush than in the culotte group [<xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Base clinical characteristics of patients undergoing crush or culotte technique</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">Crush group (<italic>n</italic> = 150)</th><th align="center" rowspan="1" colspan="1">Culotte group (<italic>n</italic> = 150)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, mean &#x000b1; SD, years</td><td align="center" rowspan="1" colspan="1">63 &#x000b1; 8</td><td align="center" rowspan="1" colspan="1">64 &#x000b1; 9</td><td align="center" rowspan="1" colspan="1">0.779</td></tr><tr><td align="left" rowspan="1" colspan="1">Male, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">109 (72.7)</td><td align="center" rowspan="1" colspan="1">111 (74.0)</td><td align="center" rowspan="1" colspan="1">0.794</td></tr><tr><td align="left" rowspan="1" colspan="1">Current smoker, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">58 (38.7)</td><td align="center" rowspan="1" colspan="1">67 (44.7)</td><td align="center" rowspan="1" colspan="1">0.292</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">106 (70.7)</td><td align="center" rowspan="1" colspan="1">109 (72.7)</td><td align="center" rowspan="1" colspan="1">0.701</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypercholesterolemia, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">114 (76.0)</td><td align="center" rowspan="1" colspan="1">105 (70.0)</td><td align="center" rowspan="1" colspan="1">0.242</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">33 (22.0)</td><td align="center" rowspan="1" colspan="1">37 (24.7)</td><td align="center" rowspan="1" colspan="1">0.585</td></tr><tr><td align="left" rowspan="1" colspan="1">Family history, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">45 (30.0)</td><td align="center" rowspan="1" colspan="1">52 (34.7)</td><td align="center" rowspan="1" colspan="1">0.388</td></tr><tr><td align="left" rowspan="1" colspan="1">Prior PCI, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">40 (26.7)</td><td align="center" rowspan="1" colspan="1">34 (22.7)</td><td align="center" rowspan="1" colspan="1">0.422</td></tr><tr><td align="left" rowspan="1" colspan="1">Indication, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Unstable angina</td><td align="center" rowspan="1" colspan="1">124 (82.7)</td><td align="center" rowspan="1" colspan="1">129 (86.0)</td><td align="center" rowspan="1" colspan="1">0.427</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Stable angina</td><td align="center" rowspan="1" colspan="1">14 (9.3)</td><td align="center" rowspan="1" colspan="1">12 (8.0)</td><td align="center" rowspan="1" colspan="1">0.681</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Silent ischemia</td><td align="center" rowspan="1" colspan="1">12 (8.0)</td><td align="center" rowspan="1" colspan="1">9 (6.0)</td><td align="center" rowspan="1" colspan="1">0.497</td></tr><tr><td align="left" rowspan="1" colspan="1">Antiplatelet therapy, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Aspirin</td><td align="center" rowspan="1" colspan="1">148 (98.7)</td><td align="center" rowspan="1" colspan="1">150 (100.0)</td><td align="center" rowspan="1" colspan="1">0.498</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Clopidogrel</td><td align="center" rowspan="1" colspan="1">150 (100.0)</td><td align="center" rowspan="1" colspan="1">149 (99.3)</td><td align="center" rowspan="1" colspan="1">0.500</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;GP IIb/IIIa inhibitors</td><td align="center" rowspan="1" colspan="1">47 (31.3)</td><td align="center" rowspan="1" colspan="1">41 (27.3)</td><td align="center" rowspan="1" colspan="1">0.447</td></tr></tbody></table><table-wrap-foot><fn><p>Values are <italic>n</italic> (%) or mean &#x000b1; SD. Independent-samples <italic>t</italic>-test or Fisher's exact test were used. SD: Standard deviation; PCI: Percutaneous coronary intervention; GP: Glycoprotein.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Procedural characteristics of crush group and culotte group</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">Crush group (<italic>n</italic> = 150)</th><th align="center" rowspan="1" colspan="1">Culotte group (<italic>n</italic> = 150)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Medina classification, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Medina 1,1,1</td><td align="center" rowspan="1" colspan="1">109 (72.7)</td><td align="center" rowspan="1" colspan="1">111 (74.0)</td><td align="center" rowspan="1" colspan="1">0.794</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Medina 0,1,1</td><td align="center" rowspan="1" colspan="1">14 (9.3)</td><td align="center" rowspan="1" colspan="1">7 (4.7)</td><td align="center" rowspan="1" colspan="1">0.113</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Medina 1,0,1</td><td align="center" rowspan="1" colspan="1">27 (18.0)</td><td align="center" rowspan="1" colspan="1">32 (21.3)</td><td align="center" rowspan="1" colspan="1">0.468</td></tr><tr><td align="left" rowspan="1" colspan="1">Lesion location, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Left main</td><td align="center" rowspan="1" colspan="1">13 (8.7)</td><td align="center" rowspan="1" colspan="1">19 (12.7)</td><td align="center" rowspan="1" colspan="1">0.262</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Left anterior descending artery</td><td align="center" rowspan="1" colspan="1">96 (64.0)</td><td align="center" rowspan="1" colspan="1">102 (68.0)</td><td align="center" rowspan="1" colspan="1">0.465</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Circumflex artery</td><td align="center" rowspan="1" colspan="1">35 (23.3)</td><td align="center" rowspan="1" colspan="1">26 (17.3)</td><td align="center" rowspan="1" colspan="1">0.197</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Right coronary artery</td><td align="center" rowspan="1" colspan="1">6 (4.0)</td><td align="center" rowspan="1" colspan="1">3 (2.0)</td><td align="center" rowspan="1" colspan="1">0.498</td></tr><tr><td align="left" rowspan="1" colspan="1">Lesion length, mean &#x000b1; SD, mm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Main vessel</td><td align="center" rowspan="1" colspan="1">16.1 &#x000b1; 6.3</td><td align="center" rowspan="1" colspan="1">18.5 &#x000b1; 7.6</td><td align="center" rowspan="1" colspan="1">0.278</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Side branch</td><td align="center" rowspan="1" colspan="1">7.9 &#x000b1; 4.1</td><td align="center" rowspan="1" colspan="1">7.4 &#x000b1; 4.3</td><td align="center" rowspan="1" colspan="1">0.703</td></tr><tr><td align="left" rowspan="1" colspan="1">Stent length, mm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Main vessel</td><td align="center" rowspan="1" colspan="1">22.8 &#x000b1; 7.5</td><td align="center" rowspan="1" colspan="1">24.6 &#x000b1; 6.7</td><td align="center" rowspan="1" colspan="1">0.427</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Side branch</td><td align="center" rowspan="1" colspan="1">10.4 &#x000b1; 5.6</td><td align="center" rowspan="1" colspan="1">10.2 &#x000b1; 5.8</td><td align="center" rowspan="1" colspan="1">0.914</td></tr><tr><td align="left" rowspan="1" colspan="1">Proximal reference diameter, mean &#x000b1; SD, mm</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Main vessel</td><td align="center" rowspan="1" colspan="1">3.4 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">3.3 &#x000b1; 0.5</td><td align="center" rowspan="1" colspan="1">0.424</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Side branch</td><td align="center" rowspan="1" colspan="1">2.6 &#x000b1; 0.3</td><td align="center" rowspan="1" colspan="1">2.7 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">0.242</td></tr><tr><td align="left" rowspan="1" colspan="1">SYNTAX score (points)</td><td align="center" rowspan="1" colspan="1">21.6 &#x000b1; 6.3</td><td align="center" rowspan="1" colspan="1">22.4 &#x000b1; 5.8</td><td align="center" rowspan="1" colspan="1">0.628</td></tr><tr><td align="left" rowspan="1" colspan="1">Final kissing balloon dilatation, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">107 (71.3)</td><td align="center" rowspan="1" colspan="1">129 (86.0)</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Angiographic success, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">145 (96.7)</td><td align="center" rowspan="1" colspan="1">148 (98.7)</td><td align="center" rowspan="1" colspan="1">0.444</td></tr><tr><td align="left" rowspan="1" colspan="1">Procedural time, mean &#x000b1; SD, min</td><td align="center" rowspan="1" colspan="1">74 &#x000b1; 20</td><td align="center" rowspan="1" colspan="1">70 &#x000b1; 17</td><td align="center" rowspan="1" colspan="1">0.467</td></tr><tr><td align="left" rowspan="1" colspan="1">Fluoroscopy time, mean &#x000b1; SD, min</td><td align="center" rowspan="1" colspan="1">25 &#x000b1; 11</td><td align="center" rowspan="1" colspan="1">24 &#x000b1; 9</td><td align="center" rowspan="1" colspan="1">0.628</td></tr><tr><td align="left" rowspan="1" colspan="1">Contrast volume, mean &#x000b1; SD, ml</td><td align="center" rowspan="1" colspan="1">152 &#x000b1; 37</td><td align="center" rowspan="1" colspan="1">138 &#x000b1; 35</td><td align="center" rowspan="1" colspan="1">0.246</td></tr></tbody></table><table-wrap-foot><fn><p>Independent-samples <italic>t</italic>-test or Fisher's exact test was used. SD: Standard deviation.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2-9"><title>Clinical outcome</title><p>The rates of event-free survival for MACE after 12 months follow-up are shown in <xref ref-type="fig" rid="F1">Figure 1</xref>. The individual endpoints after 12 months are shown in <xref ref-type="table" rid="T3">Table 3</xref>. The incidence of individual endpoints was low in both the two groups. Index lesion restenosis rates were found 12.7% versus 6.0% (<italic>P</italic> = 0.047) in the crush and culotte groups by 12 months, respectively.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Major adverse cardiac event-free survival rate at 12 months. The rate was 93.3% in the crush group, and it was 94.7% in the culotte group (<italic>P</italic> = 0.48).</p></caption><graphic xlink:href="CMJ-129-505-g001"/></fig><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Individual endpoints after 12 months in crush group and culotte group</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Items</th><th align="center" rowspan="1" colspan="1">Crush group (<italic>n</italic> = 150)</th><th align="center" rowspan="1" colspan="1">Culotte group (<italic>n</italic> = 150)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Total death, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">2 (1.3)</td><td align="center" rowspan="1" colspan="1">1 (0.7)</td><td align="center" rowspan="1" colspan="1">0.624</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiac death, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">2 (1.3)</td><td align="center" rowspan="1" colspan="1">1 (0.7)</td><td align="center" rowspan="1" colspan="1">0.624</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial infarction, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">7 (4.7)</td><td align="center" rowspan="1" colspan="1">3 (2.0)</td><td align="center" rowspan="1" colspan="1">0.335</td></tr><tr><td align="left" rowspan="1" colspan="1">Stent thrombosis, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">4 (2.7)</td><td align="center" rowspan="1" colspan="1">2 (1.3)</td><td align="center" rowspan="1" colspan="1">0.684</td></tr><tr><td align="left" rowspan="1" colspan="1">Target lesion revascularization, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">8 (5.3)</td><td align="center" rowspan="1" colspan="1">6 (4.0)</td><td align="center" rowspan="1" colspan="1">0.584</td></tr><tr><td align="left" rowspan="1" colspan="1">Target vessel revascularization, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">9 (6.0)</td><td align="center" rowspan="1" colspan="1">7 (4.7)</td><td align="center" rowspan="1" colspan="1">0.607</td></tr><tr><td align="left" rowspan="1" colspan="1">Index lesion restenosis, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">19 (12.7)</td><td align="center" rowspan="1" colspan="1">9 (6.0)</td><td align="center" rowspan="1" colspan="1">0.047</td></tr></tbody></table><table-wrap-foot><fn><p>Values are <italic>n</italic> (%). Fisher's exact test was used.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2-10"><title>Quantitative coronary angiography analysis</title><p>Minimal lumen diameter, acute gain, and late loss were similar in the two groups [<xref ref-type="table" rid="T4">Table 4</xref>]. There was 14 (9.3%) in-stent restenosis at SB in the crush group and 5 (3.3%) in the culotte group (<italic>P</italic> = 0.033), mostly located at the ostium of SB.</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Quantitative coronary analysis for main vessel and side branch</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Items</th><th align="center" rowspan="1" colspan="1">Crush group (<italic>n</italic> = 150)</th><th align="center" rowspan="1" colspan="1">Culotte group (<italic>n</italic> = 150)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Proximal main vessel segment</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Minimal luminal diameter, mean &#x000b1; SD, mm</td><td align="center" rowspan="1" colspan="1">1.85 &#x000b1; 0.49</td><td align="center" rowspan="1" colspan="1">1.87 &#x000b1; 0.46</td><td align="center" rowspan="1" colspan="1">0.882</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Acute gain</td><td align="center" rowspan="1" colspan="1">1.89 &#x000b1; 0.39</td><td align="center" rowspan="1" colspan="1">1.93 &#x000b1; 0.42</td><td align="center" rowspan="1" colspan="1">0.792</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Late loss</td><td align="center" rowspan="1" colspan="1">0.28 &#x000b1; 0.18</td><td align="center" rowspan="1" colspan="1">0.25 &#x000b1; 0.22</td><td align="center" rowspan="1" colspan="1">0.718</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Diameter stenosis, mean &#x000b1; SD, %</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Prior stenting</td><td align="center" rowspan="1" colspan="1">56.06 &#x000b1; 8.72</td><td align="center" rowspan="1" colspan="1">57.19 &#x000b1; 10.13</td><td align="center" rowspan="1" colspan="1">0.708</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;After PCI</td><td align="center" rowspan="1" colspan="1">8.95 &#x000b1; 5.31</td><td align="center" rowspan="1" colspan="1">8.43 &#x000b1; 4.92</td><td align="center" rowspan="1" colspan="1">0.753</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Follow-up</td><td align="center" rowspan="1" colspan="1">12.52 &#x000b1; 7.60</td><td align="center" rowspan="1" colspan="1">11.90 &#x000b1; 6.99</td><td align="center" rowspan="1" colspan="1">0.792</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Restenosis, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;In-stent</td><td align="center" rowspan="1" colspan="1">0 (0)</td><td align="center" rowspan="1" colspan="1">0 (0)</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Edge</td><td align="center" rowspan="1" colspan="1">2 (1.3)</td><td align="center" rowspan="1" colspan="1">1 (0.7)</td><td align="center" rowspan="1" colspan="1">0.624</td></tr><tr><td align="left" rowspan="1" colspan="1">Distal main branch segment</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Minimal luminal diameter, mean &#x000b1; SD, mm</td><td align="center" rowspan="1" colspan="1">1.42 &#x000b1; 0.45</td><td align="center" rowspan="1" colspan="1">1.47 &#x000b1; 0.38</td><td align="center" rowspan="1" colspan="1">0.664</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Acute gain</td><td align="center" rowspan="1" colspan="1">1.71 &#x000b1; 0.36</td><td align="center" rowspan="1" colspan="1">1.74 &#x000b1; 0.31</td><td align="center" rowspan="1" colspan="1">0.788</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Late loss</td><td align="center" rowspan="1" colspan="1">0.26 &#x000b1; 0.24</td><td align="center" rowspan="1" colspan="1">0.22 &#x000b1; 0.19</td><td align="center" rowspan="1" colspan="1">0.540</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Diameter stenosis, mean &#x000b1; SD, %</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Prior stenting</td><td align="center" rowspan="1" colspan="1">63.93 &#x000b1; 7.85</td><td align="center" rowspan="1" colspan="1">66.33 &#x000b1; 9.37</td><td align="center" rowspan="1" colspan="1">0.384</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;After PCI</td><td align="center" rowspan="1" colspan="1">11.48 &#x000b1; 7.93</td><td align="center" rowspan="1" colspan="1">11.26 &#x000b1; 6.69</td><td align="center" rowspan="1" colspan="1">0.926</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Follow-up</td><td align="center" rowspan="1" colspan="1">18.80 &#x000b1; 10.78</td><td align="center" rowspan="1" colspan="1">16.45 &#x000b1; 10.63</td><td align="center" rowspan="1" colspan="1">0.492</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Restenosis, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;In-stent</td><td align="center" rowspan="1" colspan="1">2 (1.3)</td><td align="center" rowspan="1" colspan="1">1 (0.7)</td><td align="center" rowspan="1" colspan="1">0.624</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Edge</td><td align="center" rowspan="1" colspan="1">3 (2.0)</td><td align="center" rowspan="1" colspan="1">1 (0.7)</td><td align="center" rowspan="1" colspan="1">0.622</td></tr><tr><td align="left" rowspan="1" colspan="1">Side branch</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Minimal luminal diameter, mean &#x000b1; SD, mm</td><td align="center" rowspan="1" colspan="1">1.23 &#x000b1; 0.34</td><td align="center" rowspan="1" colspan="1">1.32 &#x000b1; 0.29</td><td align="center" rowspan="1" colspan="1">0.345</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Acute gain</td><td align="center" rowspan="1" colspan="1">1.32 &#x000b1; 0.36</td><td align="center" rowspan="1" colspan="1">1.35 &#x000b1; 0.31</td><td align="center" rowspan="1" colspan="1">0.736</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Late loss</td><td align="center" rowspan="1" colspan="1">0.23 &#x000b1; 0.24</td><td align="center" rowspan="1" colspan="1">0.25 &#x000b1; 0.24</td><td align="center" rowspan="1" colspan="1">0.848</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Diameter stenosis, mean &#x000b1; SD, %</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Prior stenting</td><td align="center" rowspan="1" colspan="1">55.62 &#x000b1; 10.42</td><td align="center" rowspan="1" colspan="1">56.25 &#x000b1; 11.81</td><td align="center" rowspan="1" colspan="1">0.859</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;After PCI</td><td align="center" rowspan="1" colspan="1">14.26 &#x000b1; 11.20</td><td align="center" rowspan="1" colspan="1">13.02 &#x000b1; 10.45</td><td align="center" rowspan="1" colspan="1">0.720</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Follow-up</td><td align="center" rowspan="1" colspan="1">20.94 &#x000b1; 12.77</td><td align="center" rowspan="1" colspan="1">17.61 &#x000b1; 10.57</td><td align="center" rowspan="1" colspan="1">0.375</td></tr><tr><td align="left" rowspan="1" colspan="1">Restenosis, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;In-stent</td><td align="center" rowspan="1" colspan="1">14 (9.3)</td><td align="center" rowspan="1" colspan="1">5 (3.3)</td><td align="center" rowspan="1" colspan="1">0.033</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;Edge</td><td align="center" rowspan="1" colspan="1">4 (2.7)</td><td align="center" rowspan="1" colspan="1">5 (3.3)</td><td align="center" rowspan="1" colspan="1">0.735</td></tr><tr><td colspan="4" rowspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>Values are mean &#x000b1; SD or <italic>n</italic> (%). Restenosis was defined as &#x02265;50% diameter stenosis at 12-month follow-up. SD: Standard deviation; PCI: Percutaneous coronary intervention; NA: Not applicable.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2-11"><title>Computational fluid dynamics analysis</title><p><xref ref-type="fig" rid="F2">Figure 2</xref> showed coronary angiography pre-PCI, post-PCI, and at 12-month follow-up of a representative bifurcation lesion and its corresponding CFD results. The surface integral of TAWSS was both similar in the two groups at baseline and post-PCI (<italic>P</italic> &#x0003e; 0.05). However, at 12-month follow-up, the surface integral of TAWSS of the bifurcation site in the crush group was significantly lower than that in the culotte group ([5.01 &#x000b1; 0.95] &#x000d7; 10<sup>&#x02212;4</sup> Newton and [6.08 &#x000b1; 1.16] &#x000d7; 10<sup>&#x02212;4</sup> Newton, respectively; <italic>P</italic> = 0.003).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>(a) Angiography left anterior oblique cranial view of a left anterior descending-diagonal true bifurcation lesion pre percutaneous coronary intervention. (b) Left anterior oblique cranial view after culotte stenting technique. (c) Left anterior oblique cranial view (12-month follow-up). (d) Right anterior oblique cranial view (12-month follow-up). (e) Three-dimensional geometry at 12-month follow-up. (f) Mesh model at 12-month follow-up. (g) Scalar of time-averaged wall shears stress at 12-month follow-up.</p></caption><graphic xlink:href="CMJ-129-505-g002"/></fig></sec></sec><sec sec-type="discussion" id="sec1-4"><title>D<sc>ISCUSSION</sc></title><p>We compared the crush with the culotte bifurcation stenting technique in this randomized study and made several novel observations which as follows: (1) low and similar 12-month MACE rates were found in two study groups. Both the crush and the culotte bifurcation stenting techniques showed satisfying clinical and angiographic results by 12 months. (2) There was a trend toward less restenosis in patients treated with the culotte stenting technique. (3) Compared with the crush stenting technique, the culotte stenting technique was associated with more favorable flow profile by 12 months follow-up.</p><p>Based on the results of several randomized clinical trials, the provisional SB stenting technique is considered the default strategy for bifurcation lesions at present.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref11" ref-type="bibr">11</xref>] However, despite the current consensus on the single stenting technique, some complex bifurcation lesions, especially with a large SB or serious stenosis at the ostium of the SB may still need double stenting techniques in order to provide full stent coverage of the bifurcation area. We evaluated the crush and the culotte bifurcation techniques which are most commonly double stenting techniques in clinical practice in this study. The 12-month follow-up data showed that both the crush and the culotte stenting technique were associated with low MACE rates (6.7% and 5.3%, respectively) and satisfying clinical results. The definite stent thrombosis rates were 2.7% and 1.3% (<italic>P</italic> = 0.68) in the crush and culotte groups, respectively. This result is in line with previous studies which suggested that the rate of ST is 3% more or less for bifurcation lesions treated with a double stenting technique. Kaplan <italic>et al</italic>.[<xref rid="ref12" ref-type="bibr">12</xref>] compared the culotte with the T-stenting technique in a nonrandomized study. After 9-month follow-up, they found that there was a trend toward lower MACE rate in the culotte group than the T-stenting group (13.3% and 27.3%, respectively). The stent thrombosis rate of the culotte group was 2.2% at 9 months in this study. In another multicenter prospective clinical trail, 134 bifurcation lesions in 132 patients were treated with the culotte technique and the incidence of stent thrombosis was 1.5% at 12 months.[<xref rid="ref13" ref-type="bibr">13</xref>] Regarding the crush stenting technique, a single center prospective registry study enrolled 100 patients treated with the crush technique. After 3-year follow-up, the stent thrombosis rate was 3% and the TVR rate was 11%.[<xref rid="ref14" ref-type="bibr">14</xref>] Similar to these clinical trials, the low stent thrombosis rates in the present study further convince the fact that both the crush and the culotte stenting techniques are safe for the treatment of complex bifurcation lesions.</p><p>The numerically higher restenosis rate in the crush stenting technique group is in keeping with results of other large clinical trials. In the Nordic Stent Technique Study, 424 patients were enrolled and in-stent restenosis rates after 8 months were found 10.5% versus 4.5% (<italic>P</italic> = 0.046) in the crush and culotte groups, respectively.[<xref rid="ref15" ref-type="bibr">15</xref>] In another prospective registry study, 100 patients were treated with the crush stenting technique and target lesion revascularization rate was 11% by 3-year follow-up.[<xref rid="ref14" ref-type="bibr">14</xref>] These results may be explained by the lower success rate of final kissing balloon dilatation in the operation process and more disturbed flow pattern after the treatment in the crush-treated group.</p><p>Final kissing balloon dilatation are generally recommended in double stenting techniques to improve clinical outcome and prevent SB reocclusion.[<xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref17" ref-type="bibr">17</xref>] In the crush-treated patients, three layers of struts covering the SB ostium make the rewiring and balloon insertion through stent struts laborious. Nevertheless, the observed lower success rate of final kissing balloon dilatation did not result in high target lesion revascularization rates in the present study. This may partly be explained by the fact that malapposed struts at the SB ostium are not always angiographically visible and become apparent only when neointima and fibrin deposition cover the struts left jailing the ostium. On the other hand, early follow-up results in patients treated with a drug-eluting stent and antiplatelet therapies may underestimate the risk associated with leaving malapposed struts at the SB ostium. Thus, final kissing balloon dilation should be performed, whenever possible, in complex bifurcation lesions requiring double stenting technique.</p><p>Regarding flow pattern alteration after stent implantation, previous studies showed neointima hyperplasia and fibrin deposition tend to form in areas where frequently exposed to low and oscillatory shear stress. Act as a media increasing the expression of platelet-derived growth factor, endothelin-1, and vascular endothelial growth factor, low shear stress can promote the activation, proliferation, and migration of smooth muscle cells.[<xref rid="ref18" ref-type="bibr">18</xref>] In addition, low shear stress upregulates proinflammatory genes, including chemoattractant chemokines, adhesion molecules, and cytokines, thereby enhancing injury-induced inflammation.[<xref rid="ref19" ref-type="bibr">19</xref>] Thus, in theory, the coronary intervention was aimed to restore laminar flow with a high shear stress so that fibrous tissue could not proliferate. Improved hemodynamic performance-guided stent implantation may translate to improved clinical outcomes. Several studies have assessed flow patterns after stent implantation at bifurcation sites. Katritsis <italic>et al</italic>.[<xref rid="ref6" ref-type="bibr">6</xref>] studied TAWSS alterations by simulating different stenting techniques that commonly used in bifurcation lesions in idealized bifurcation models and found that crush stenting gave the most favorable results among the double stenting techniques. However, on the contrary, in another <italic>in vitro</italic> study, Foin <italic>et al</italic>.[<xref rid="ref20" ref-type="bibr">20</xref>] compared the results of different double stenting strategies and found that the crush technique resulted in a higher risk of malapposition and a more disturbed flow than either the culotte or T with protrusion stenting technique. In the present study, we calculated the surface integrals of TAWSS at the subregion of bifurcation site. Our CFD results suggested that the crush and the culotte stenting techniques do not produce similar hemodynamic disturbances at bifurcations. Lower surface integrals of TAWSS were found in the crush-treated patients than in the culotte group ([5.01 &#x000b1; 0.95] &#x000d7; 10<sup>&#x02212;4</sup> Newton and [6.08 &#x000b1; 1.16] &#x000d7; 10<sup>&#x02212;4</sup> Newton, respectively; <italic>P</italic> = 0.003). Despite we cannot directly link hemodynamic disturbances with the risk of restenosis and stent thrombosis, it is plausible that the risk of these complications would be higher if the subregion of bifurcation sites are continuously exposed to unfavorable hemodynamic conditions. However, the observed lower TAWSS in the crush group did not result in a high target lesion revascularization rates in the present study. Except for the short follow-up time, this may also partly be explained by the fact that drug-eluting stents and antiplatelet therapies alleviate the unfavorable hemodynamic effect of disturbed flow by inhibiting the neointima hyperplasia process.</p><p>According to the present results, both the crush and the culotte technique are efficient and safe for complex bifurcation lesions. The operator may choose technique on the basis of the lesion characteristics and personal experience. Compared to the crush technique, the possible hemodynamic advantages of the culotte technique still require longer follow-up and more clinical trials to further confirm.</p><p>Several limitations of the current study should be acknowledged. First, since it was an open trial, operators and patients were aware of the technique used. This may introduce information bias when to collect and analyze data at follow-up. Second, despite the rates of stent thrombosis and MACE were low after 12 months clinical and angiographic follow-up in the present study, the durability of these results on a long-term basis is not known. Finally, the accuracy of CFD analysis largely depends on the quality and precision of reconstruction. The quality of reconstruction view needs to be improved by giving more precise angiographic images of coronary bifurcation at an angle of more than 30&#x000b0;.</p><p>In conclusion, both the crush and the culotte technique were associated with an excellent clinical and angiographic results at 12-month follow-up. Bifurcation lesions treated with the culotte technique tended to have lower restenosis rates and more favorable flow patterns.</p><sec id="sec2-12"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-13"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><fn-group><fn fn-type="edited-by"><p><bold>Edited by:</bold> Li-Min Chen</p></fn></fn-group><ref-list><title>R<sc>EFERENCES</sc></title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lassen</surname><given-names>JF</given-names></name><name><surname>Holm</surname><given-names>NR</given-names></name><name><surname>Stankovic</surname><given-names>G</given-names></name><name><surname>Lef&#x000e8;vre</surname><given-names>T</given-names></name><name><surname>Chieffo</surname><given-names>A</given-names></name><name><surname>Hildick-Smith</surname><given-names>D</given-names></name><etal/></person-group><article-title>Percutaneous coronary intervention for coronary bifurcation disease: Consensus from the first 10 years of the European Bifurcation Club meetings</article-title><source>EuroIntervention</source><year>2014</year><volume>10</volume><fpage>545</fpage><lpage>60</lpage><comment>doi: 10.4244/EIJV10I5A97</comment><pub-id pub-id-type="pmid">25256198</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kornowski</surname><given-names>R</given-names></name></person-group><article-title>The complexity of stenting in bifurcation coronary lesions</article-title><source>JACC Cardiovasc Interv</source><year>2013</year><volume>6</volume><fpage>696</fpage><lpage>7</lpage><comment>doi: 10.1016/j.jcin.2013.04.005</comment><pub-id pub-id-type="pmid">23866181</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeng</surname><given-names>M</given-names></name><name><surname>Holm</surname><given-names>NR</given-names></name><name><surname>Erglis</surname><given-names>A</given-names></name><name><surname>Kumsars</surname><given-names>I</given-names></name><name><surname>Niemel&#x000e4;</surname><given-names>M</given-names></name><name><surname>Kervinen</surname><given-names>K</given-names></name><etal/></person-group><article-title>Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results</article-title><source>J Am Coll Cardiol</source><year>2013</year><volume>62</volume><fpage>30</fpage><lpage>4</lpage><comment>doi: 10.1016/j.jacc.2013.04.015</comment><pub-id pub-id-type="pmid">23644088</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatzizisis</surname><given-names>YS</given-names></name><name><surname>Giannoglou</surname><given-names>GD</given-names></name></person-group><article-title>Shear stress and inflammation: Are we getting closer to the prediction of vulnerable plaque?</article-title><source>Expert Rev Cardiovasc Ther</source><year>2010</year><volume>8</volume><fpage>1351</fpage><lpage>3</lpage><comment>doi: 10.1586/erc.10.126</comment><pub-id pub-id-type="pmid">20936918</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Tempel</surname><given-names>D</given-names></name><name><surname>van Haperen</surname><given-names>R</given-names></name><name><surname>van der Baan</surname><given-names>A</given-names></name><name><surname>Grosveld</surname><given-names>F</given-names></name><name><surname>Daemen</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress</article-title><source>Circulation</source><year>2006</year><volume>113</volume><fpage>2744</fpage><lpage>53</lpage><comment>doi: 10.1161/CIRCULATIONAHA.105.590018</comment><pub-id pub-id-type="pmid">16754802</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katritsis</surname><given-names>DG</given-names></name><name><surname>Theodorakakos</surname><given-names>A</given-names></name><name><surname>Pantos</surname><given-names>I</given-names></name><name><surname>Gavaises</surname><given-names>M</given-names></name><name><surname>Karcanias</surname><given-names>N</given-names></name><name><surname>Efstathopoulos</surname><given-names>EP</given-names></name></person-group><article-title>Flow patterns at stented coronary bifurcations: Computational fluid dynamics analysis</article-title><source>Circ Cardiovasc Interv</source><year>2012</year><volume>5</volume><fpage>530</fpage><lpage>9</lpage><comment>doi: 10.1161/CIRCINTERVENTIONS.112.968347</comment><pub-id pub-id-type="pmid">22763345</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Rong</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><etal/></person-group><article-title>Three-dimensional virtual surgery models for percutaneous coronary intervention (PCI) optimization strategies</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>10945</fpage><comment>doi: 10.1038/srep10945</comment><pub-id pub-id-type="pmid">26042609</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname><given-names>A</given-names></name><name><surname>Stankovic</surname><given-names>G</given-names></name><name><surname>Orlic</surname><given-names>D</given-names></name><name><surname>Corvaja</surname><given-names>N</given-names></name><name><surname>Liistro</surname><given-names>F</given-names></name><name><surname>Airoldi</surname><given-names>F</given-names></name><etal/></person-group><article-title>Modified T-stenting technique with crushing for bifurcation lesions: Immediate results and 30-day outcome</article-title><source>Catheter Cardiovasc Interv</source><year>2003</year><volume>60</volume><fpage>145</fpage><lpage>51</lpage><comment>doi: 10.1002/ccd.10622</comment><pub-id pub-id-type="pmid">14517916</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chevalier</surname><given-names>B</given-names></name><name><surname>Glatt</surname><given-names>B</given-names></name><name><surname>Royer</surname><given-names>T</given-names></name><name><surname>Guyon</surname><given-names>P</given-names></name></person-group><article-title>Placement of coronary stents in bifurcation lesions by the &#x0201c;culotte&#x0201d; technique</article-title><source>Am J Cardiol</source><year>1998</year><volume>82</volume><fpage>943</fpage><lpage>9</lpage><comment>doi: 10.1016/S0002-9149(98)00510-4</comment><pub-id pub-id-type="pmid">9794349</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauri</surname><given-names>L</given-names></name><name><surname>Hsieh</surname><given-names>WH</given-names></name><name><surname>Massaro</surname><given-names>JM</given-names></name><name><surname>Ho</surname><given-names>KK</given-names></name><name><surname>D&#x02019;Agostino</surname><given-names>R</given-names></name><name><surname>Cutlip</surname><given-names>DE</given-names></name></person-group><article-title>Stent thrombosis in randomized clinical trials of drug-eluting stents</article-title><source>N Engl J Med</source><year>2007</year><volume>356</volume><fpage>1020</fpage><lpage>9</lpage><comment>doi: 10.1056/NEJMoa067731</comment><pub-id pub-id-type="pmid">17296821</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>PJ</given-names></name><name><surname>Chang</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>HJ</given-names></name><name><surname>Jeong</surname><given-names>MH</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><etal/></person-group><article-title>Long-term clinical outcomes of the one-stent technique versus the two-stent technique for non-left main true coronary bifurcation disease in the era of drug-eluting stents</article-title><source>J Interv Cardiol</source><year>2013</year><volume>26</volume><fpage>245</fpage><lpage>53</lpage><comment>doi: 10.1111/joic.12025</comment><pub-id pub-id-type="pmid">23480867</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>S</given-names></name><name><surname>Barlis</surname><given-names>P</given-names></name><name><surname>Dimopoulos</surname><given-names>K</given-names></name><name><surname>La</surname><given-names>Manna A</given-names></name><name><surname>Goktekin</surname><given-names>O</given-names></name><name><surname>Galassi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Culotte versus T-stenting in bifurcation lesions: Immediate clinical and angiographic results and midterm clinical follow-up</article-title><source>Am Heart J</source><year>2007</year><volume>154</volume><fpage>336</fpage><lpage>43</lpage><comment>doi: 10.1016/j.ahj.2007.04.019</comment><pub-id pub-id-type="pmid">17643585</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adriaenssens</surname><given-names>T</given-names></name><name><surname>Byrne</surname><given-names>RA</given-names></name><name><surname>Dibra</surname><given-names>A</given-names></name><name><surname>Iijima</surname><given-names>R</given-names></name><name><surname>Mehilli</surname><given-names>J</given-names></name><name><surname>Bruskina</surname><given-names>O</given-names></name><etal/></person-group><article-title>Culotte stenting technique in coronary bifurcation disease: Angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes</article-title><source>Eur Heart J</source><year>2008</year><volume>29</volume><fpage>2868</fpage><lpage>76</lpage><comment>doi: 10.1093/eurheartj/ehn512</comment><pub-id pub-id-type="pmid">19001472</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chue</surname><given-names>CD</given-names></name><name><surname>Routledge</surname><given-names>HC</given-names></name><name><surname>Ludman</surname><given-names>PF</given-names></name><name><surname>Townend</surname><given-names>JN</given-names></name><name><surname>Epstein</surname><given-names>AC</given-names></name><name><surname>Buller</surname><given-names>NP</given-names></name><etal/></person-group><article-title>3-year follow-up of 100 consecutive coronary bifurcation lesions treated with Taxus stents and the crush technique</article-title><source>Catheter Cardiovasc Interv</source><year>2010</year><volume>75</volume><fpage>605</fpage><lpage>13</lpage><comment>doi: 10.1002/ccd.22252</comment><pub-id pub-id-type="pmid">20066725</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erglis</surname><given-names>A</given-names></name><name><surname>Kumsars</surname><given-names>I</given-names></name><name><surname>Niemel&#x000e4;</surname><given-names>M</given-names></name><name><surname>Kervinen</surname><given-names>K</given-names></name><name><surname>Maeng</surname><given-names>M</given-names></name><name><surname>Lassen</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: The Nordic stent technique study</article-title><source>Circ Cardiovasc Interv</source><year>2009</year><volume>2</volume><fpage>27</fpage><lpage>34</lpage><comment>doi: 10.1161/CIRCINTERVENTIONS.108.804658</comment><pub-id pub-id-type="pmid">20031690</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biondi-Zoccai</surname><given-names>G</given-names></name><name><surname>Sheiban</surname><given-names>I</given-names></name><name><surname>De</surname><given-names>Servi S</given-names></name><name><surname>Tamburino</surname><given-names>C</given-names></name><name><surname>Sangiorgi</surname><given-names>G</given-names></name><name><surname>Romagnoli</surname><given-names>E</given-names></name></person-group><article-title>To kiss or not to kiss?Impact of final kissing-balloon inflation on early and long-term results of percutaneous coronary intervention for bifurcation lesions</article-title><source>Heart Vessels</source><year>2014</year><volume>29</volume><fpage>732</fpage><lpage>42</lpage><comment>doi: 10.1007/s00380-013-0416-0</comment><pub-id pub-id-type="pmid">24077644</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foin</surname><given-names>N</given-names></name><name><surname>Torii</surname><given-names>R</given-names></name><name><surname>Mortier</surname><given-names>P</given-names></name><name><surname>De</surname><given-names>Beule M</given-names></name><name><surname>Viceconte</surname><given-names>N</given-names></name><name><surname>Chan</surname><given-names>PH</given-names></name><etal/></person-group><article-title>Kissing balloon or sequential dilation of the side branch and main vessel for provisional stenting of bifurcations: Lessons from micro-computed tomography and computational simulations</article-title><source>JACC Cardiovasc Interv</source><year>2012</year><volume>5</volume><fpage>47</fpage><lpage>56</lpage><comment>doi: 10.1016/j.jcin.2011.08.019</comment><pub-id pub-id-type="pmid">22230150</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redmond</surname><given-names>EM</given-names></name><name><surname>Cullen</surname><given-names>JP</given-names></name><name><surname>Cahill</surname><given-names>PA</given-names></name><name><surname>Sitzmann</surname><given-names>JV</given-names></name><name><surname>Stefansson</surname><given-names>S</given-names></name><name><surname>Lawrence</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Endothelial cells inhibit flow-induced smooth muscle cell migration: Role of plasminogen activator inhibitor-1</article-title><source>Circulation</source><year>2001</year><volume>103</volume><fpage>597</fpage><lpage>603</lpage><comment>doi: 10.1161/01.CIR.103.4.597</comment><pub-id pub-id-type="pmid">11157728</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatzizisis</surname><given-names>YS</given-names></name><name><surname>Coskun</surname><given-names>AU</given-names></name><name><surname>Jonas</surname><given-names>M</given-names></name><name><surname>Edelman</surname><given-names>ER</given-names></name><name><surname>Feldman</surname><given-names>CL</given-names></name><name><surname>Stone</surname><given-names>PH</given-names></name></person-group><article-title>Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: Molecular, cellular, and vascular behavior</article-title><source>J Am Coll Cardiol</source><year>2007</year><volume>49</volume><fpage>2379</fpage><lpage>93</lpage><comment>doi: 10.1016/j.jacc.2007.02.059</comment><pub-id pub-id-type="pmid">17599600</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foin</surname><given-names>N</given-names></name><name><surname>Alegria-Barrero</surname><given-names>E</given-names></name><name><surname>Torii</surname><given-names>R</given-names></name><name><surname>Chan</surname><given-names>PH</given-names></name><name><surname>Viceconte</surname><given-names>N</given-names></name><name><surname>Davies</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Crush, culotte, T and protrusion: Which 2-stent technique for treatment of true bifurcation lesions? &#x02013; Insights from <italic>in vitro</italic> experiments and micro-computed tomography</article-title><source>Circ J</source><year>2013</year><volume>77</volume><fpage>73</fpage><lpage>80</lpage><comment>doi: 10.1253/circj.CJ-12-0272</comment><pub-id pub-id-type="pmid">23006784</pub-id></element-citation></ref></ref-list></back></article>